Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Zentalis Pharmaceuticals Inc shares valued at $13,762 were sold by Lackner Mark on Jan 02 ’25. At $3.12 per share, Lackner Mark sold 4,411 shares. The insider’s holdings dropped to 191,317 shares worth approximately $0.44 million following the completion of this transaction.
Also, Diana Hausman purchased 9,888 shares, netting a total of over 28,294 in proceeds.
Before that, Vultaggio Vincent had sold 1,603 shares from its account. In a trade valued at $5,098, the Principal Accounting Officer traded Zentalis Pharmaceuticals Inc shares for $3.18 each. Upon closing the transaction, the insider’s holdings decreased to 1,603 shares, worth approximately $77866.5.
As published in a research note from Wedbush on August 12, 2024, Zentalis Pharmaceuticals Inc [ZNTL] has been rated up from an Underperform to a Neutral and the price target has been revised to $4. Analysts at UBS downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in mid June. As of June 18, 2024, Wells Fargo has decreased its “an Overweight” rating to a “an Equal weight” for ZNTL. Earlier on June 18, 2024, Wedbush downgraded its rating. Their new recommendation was “an Underperform” for ZNTL stock which previously was a “a Neutral”.
Analyzing ZNTL Stock Performance
During the last five days, there has been a drop of approximately -19.30%. Over the course of the year, Zentalis Pharmaceuticals Inc shares have dropped approximately -24.09%. Shares of the company reached a 52-week high of $3.33 on 01/03/25 and a 52-week low of $2.13 on 01/23/25. A 50-day SMA is recorded $3.17, while a 200-day SMA reached $5.53. Nevertheless, trading volume fell to 2.37 million shares from 2.9 million shares the previous day.
Support And Resistance Levels for Zentalis Pharmaceuticals Inc (ZNTL)
According to the 24-hour chart, there is a support level at 2.17, which, if violated, would cause prices to drop to 2.03. In the upper region, resistance lies at 2.40. The next price resistance is at 2.49. RSI (Relative Strength Index) is 34.79 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.40, which suggests the price will decrease in the coming days. Percent R is at 85.83%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
